Is it? Or is the market just discounting the lower purchasing power of the dollar that is to come and adjusting stock prices as measured in future dollars.
*BIDEN: STIMULUS PACKAGE TO BE IN TRILLIONS OF DOLLARS *BIDEN: WILL LAY OUT STIMULUS PACKAGE DETAILS NEXT THURSDAY *BIDEN SAYS HIS STIMULUS PACKAGE PRICE TAG WILL BE `HIGH' 10-year yields headed back toward session highs
Arcturus $ARCT getting creamed as Phase 1/2 for ARCT-021 self-replicating Alphavirus-derived replicon RNA vaccine for COVID-19 shows neutralizing antibody titers of only 32, 33 and 46, following 5 µg single dose, 7.5 µg single dose and 5 µg boost. It should of had titers in the hundreds. Queue JPG of low titers.
As an aside - if you have kids and have anything to do with schools re-opening please consider this paper - it is the best I've read all year on the subject:
Numerical investigation of aerosol transport in a classroom with relevance to COVID-19
aip.scitation.org/doi/10.1063/5.0029118
Merck's MK4482 (was EIDD-2801) has a lot of very important people set to benefit if Phase II trials go well (primary end point in October and study end in November). Cheap to make, kills SARS-CoV-2 and oral i.e. all the drawbacks of Remdesivir this drug does not have. Some posit it may be a mutagen. We'll see. But given how high up some of the people involved are who are involved in this drug it will likely get the benefit of the doubt from the FDA if the results are even marginally acceptable (there are some very irregular things going on in the funding/development). Best of all - they have n
Tokyo hits the 48% seroprevalence mark with a low fatality rate. A drop in new cases seems to indicate they have reached herd immunity:
https://www.medrxiv.org/content/10.1101/2020.09.21.20198796v1.full.pdf+html
.thumb.jpeg.117bf21a379afc82ddc1d204f0ebaac6.jpeg)
